Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to take part in the study
- You are able to communicate without difficulty
- You are 18 years of age or older
- You live at the center where the study is taking place
- You do not have any cuts, scratches, or physical abnormalities in the area where treatment would be applied
- You do not smoke, use recreational drugs, or take tranquilizers, and you are not pregnant
- You have been receiving treatment for Multiple Sclerosis (MS) for more than three months
Who may not be able to join:
- You smoke, use substances, or take tranquilizers
- You have difficulty breathing or shortness of breath
- You have anemia (low red blood cell levels)
- You have diabetes
- You have received corticosteroid (steroid) treatment within the last three months
- You have had an MS relapse (attack) within the last three months
- You have an autoimmune disease other than MS
- You currently show signs of an infection
- You have a thyroid condition
- You are taking stimulant medications
- You have been found to have anxiety or depression during clinic check-ups
- You do not wish to take part in the study
- You have another known neurological condition, such as dementia or Alzheimer's disease
- You have difficulty communicating
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Caner F Demir, MD, Firat University
Phone: +905442772249
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The Multiple Sclerosis Quality of Life; The Multiple Sclerosis Functional Composite
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.